February 1, 2007
Ranbaxy successful in PM(NOC) proceeding on Pfizer's atorvastatin patent

November 3, 2006
Supreme Court of Canada considers the Patented Medicines (Notice of Compliance) regulations
Drug must be on sale in Canada for patents to be listed under the PM(NOC) regulations

[ Archives ][ Search ]